Status:
COMPLETED
Effect of Ready to Use Therapeutic Food (RUTF) Supplement After an Episode of Malaria Falciparum on Weight
Lead Sponsor:
Medecins Sans Frontieres, Netherlands
Conditions:
Weight Loss
Weight Gain
Eligibility:
All Genders
6-59 years
Phase:
NA
Brief Summary
The primary objective of this study is to determine to what extent provision with RUTF will promote catch up growth in children following an acute uncomplicated episode of P. falciparum malaria.
Detailed Description
Anorexia due to infection might lead to weight loss. In many settings total recovery is problematic what might result in a permanent lower weight. A short period high quality food supplementation coul...
Eligibility Criteria
Inclusion
- Age 6 to 59 months, and
- Positive rapid diagnostic test (Paracheck®) and
- Thick smear showing infection with P. falciparum and
- Informed consent from parents or guardian aged at least 18 years.
Exclusion
- Children who are exclusively breast fed or
- Children who are severely malnourished (MUAC \<110 mm and/or bilateral oedema, or WHO weight-for-Height criteria \<3 Z-scores) or
- Presence of general danger signs or signs of severe malaria as defined by the WHO criteria, or
- Known history of allergy to malaria drugs, or
- Having a sibling enrolled in the study.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00819858
Start Date
January 1 2009
End Date
March 1 2009
Last Update
October 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Hospital
Dubie, Katanga, Republic of the Congo